The human brain is a mystery. Although enormous strides have been made to understand how it works and how our neuro pathways respond to various stimuli, there is still so much we don’t know.
For people with epilepsy, particularly with Lennox-Gastaut syndrome (LGS), a vexing seizure condition that is resistant to standard medical therapies, understanding the inner workings of the brain can be the difference between life and death.
Lately, significant progress has been made in finding new methods of treatment for Lennox-Gastaut syndrome as doctors and researchers around the world contribute to the pool of understanding and knowledge. According to an article in Culture magazine, in Mexico, Dr. Saul Garza Morales may have found an answer for those suffering with LGS.
In the results of a study he released earlier this year, Morales found that children with LGS responded positively to treatment with Real Scientific Hemp Oil-X (RSHO-X). Thirty-nine patients were treated with 84% experiencing a reduction in motor seizures. Seventeen percent were seizure-free over a four-month period. No side effects were reported. Although the study size is not large enough to claim conclusive results, the initial report may bring hope to families living with this chronic condition.
Around the world, several pharmaceutical companies are racing to bring this new therapy to market. And for people living with LGS and their loved ones, it can’t come soon enough.
According to The Childhood Neurology Foundation, “LGS is a severe childhood form of epilepsy defined by multiple, often medication-refractory seizures (usually “drop attacks”, atypical absence seizures and tonic seizures), a characteristic EEG pattern (slow waking background, slow spike wave) and paroxysmal fast rhythms in sleep) as well as cognitive, behavioral and psychiatric symptoms.”
An estimated 30,000-50,000 people in the US suffer from this condition for which there is no cure. So even limited clinical trials such as this one in Mexico are good news for those who suffer with this disease.